Gail S. Wick, MHSA, BSN, RN, CNNe

Gail Wick

Gail Wick began her career in nephrology nursing in 1970 as a member of the nursing staff that helped open the first renal ICU and transplant unit in Georgia located at Grady Memorial Hospital. Until recently, she worked as a consultant for ESRD-related care, quality, education, and policy issues contracting with dozens of freestanding and hospital based, for profit and not for profit dialysis clinics throughout the United States, as well as with manufacturers and pharmaceutical companies in the areas of new product utilization and education. Previously, Ms. Wick served as Vice President for Nursing Services at DaVita, Inc., where she was responsible for nursing manpower, care and practice for more than 540 dialysis facilities throughout the United States. Ms. Wick also worked for Fresenius USA, a dialysis product company as Director of Client Services, as well as held vice president positions at Fresenius Medical Care, North America, including Vice President of Clinical Quality Management, Clinical Services, Regulatory Affairs and Technical Services; Vice President of Corporate Marketing and Communications; and Vice President of Corporate Communications and Strategic Planning.

In addition to serving as the president of the American Nephrology Nurses Association both in 1987-88 and 2002-2003 and involvement in numerous other organizations, Ms. Wick has had over 50 articles and chapters published in professional journals and textbooks. She has given over 600 presentations in the United States and internationally. Her continued commitment to the care and welfare of persons with renal disease, as well as their access to optimal treatment and care is evidenced by her service on the Board of Trustees of the American Kidney Fund where she held the offices of Chair and serves on numerous committees. She has been actively involved with Kidney Care Partners since its inception and currently serves on numerous policy focused workgroups/steering committees such as the QIP, PPS, and Innovation policy workgroups.